Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nephrologie|March 31, 2001
[Plasminogen activator inhibitor type 1: physiology and role in renal physiopathology]J P Rerolle, C Vigneau, A Hertig, et al.
Kidney International|October 24, 2000
Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesisJ P Rerolle, A Hertig, G Nguyen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2000
Successful endoluminal thrombo-aspiration of renal graft venous thrombosisJ P Rerolle, C Antoine, A Raynaud, et al.
Clinical Transplantation|June 1, 2000
Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantationJ P Rerolle, K Akposso, N Lerolle, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 25, 2012
Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogenT Chambaraud, Z Dickson, G Ensergueix, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2012
Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER studyY Lebranchu, R Snanoudj, O Toupance, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 9, 2016
Genome-Wide Association Study of Acute Renal Graft RejectionL Ghisdal, C Baron, Y Lebranchu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 11, 2012
De novo kidney graft tumors: results from a multicentric retrospective national studyX Tillou, A Doerfler, S Collon, et al.
Pageof 1